|
|
| RLN706a | 肺腺癌组织芯片，附病理分级、TNM和临床分期，75例/75点，替代LC706 | | 点 数 | 75 | 例 数 | 75 | | 行 数 | 10 | 列 数 | 8 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
Malignant (I) Malignant (IA) Malignant (IB) Malignant (IIA) Malignant (IIB) Malignant (IIIA) Malignant (IIIB) |
|
|
TISSUE ARRAYS RLN706a |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
A | | | | | | | | | |
B | | | | | | | | | |
C | | | | | | | | | |
D | | | | | | | | | |
E | | | | | | | | | |
F | | | | | | | | | |
G | | | | | | | | | |
H | | | | | | | | | |
I | | | | | | | | | |
J | | | |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
| A1 | 1 | 54 | M | Lung | Adenocarcinoma | 1 | T2N0M0 | IB | Malignant | N |
| A2 | 2 | 65 | F | Lung | Adenocarcinoma | 1 | T2N0M0 | IB | Malignant | N |
| A3 | 3 | 61 | M | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | N |
| A4 | 4 | 53 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | N |
| A5 | 5 | 65 | M | Lung | Adenocarcinoma | 1 | T2N0MO | I | Malignant | N |
| A6 | 6 | 70 | F | Lung | Adenocarcinoma | 1 | T1N0M0 | IA | Malignant | N |
| A7 | 7 | 60 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| A8 | 8 | 67 | F | Lung | Adenocarcinoma | 2 | T3N2M0 | IIIA | Malignant | N |
| B1 | 9 | 69 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | N |
| B2 | 10 | 56 | F | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| B3 | 11 | 65 | M | Lung | Adenocarcinoma | 2 | T3N2M0 | IIIA | Malignant | N |
| B4 | 12 | 75 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| B5 | 13 | 48 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | N |
| B6 | 14 | 66 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | N |
| B7 | 15 | 64 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| B8 | 16 | 59 | F | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| C1 | 17 | 62 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| C2 | 18 | 68 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| C3 | 19 | 63 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | N |
| C4 | 20 | 64 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IIA | Malignant | N |
| C5 | 21 | 37 | F | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| C6 | 22 | 59 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | N |
| C7 | 23 | 59 | M | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | N |
| C8 | 24 | 67 | M | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| D1 | 25 | 68 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| D2 | 26 | 72 | F | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| D3 | 27 | 82 | M | Lung | Adenocarcinoma | 3 | T4N1M0 | IIIA | Malignant | N |
| D4 | 28 | 71 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | I | Malignant | N |
| D5 | 29 | 42 | M | Lung | Adenocarcinoma | 3 | T1N0M0 | IB | Malignant | N |
| D6 | 30 | 52 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| D7 | 31 | 75 | F | Lung | Adenocarcinoma | - | T2N1M0 | IIB | Malignant | N |
| D8 | 32 | 70 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| E1 | 33 | 54 | F | Lung | Adenocarcinoma | 3 | T4N1M0 | IIIA | Malignant | N |
| E2 | 34 | 47 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| E3 | 35 | 38 | M | Lung | Adenocarcinoma | 3 | T4N1M0 | IIIA | Malignant | N |
| E4 | 36 | 32 | F | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| E5 | 37 | 65 | F | Lung | Adenocarcinoma | 3 | T2N2M0 | IIIA | Malignant | N |
| E6 | 38 | 38 | M | Lung | Adenocarcinoma | 2 | T4N2M0 | IIIB | Malignant | N |
| E7 | 39 | 57 | M | Lung | Adenocarcinoma | 3 | T4N0M0 | IIIA | Malignant | N |
| E8 | 40 | 52 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| F1 | 41 | 72 | M | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| F2 | 42 | 39 | F | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| F3 | 43 | 61 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| F4 | 44 | 59 | M | Lung | Adenocarcinoma | 2 | T4N3M0 | IIIB | Malignant | N |
| F5 | 45 | 59 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | N |
| F6 | 46 | 64 | F | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| F7 | 47 | 49 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| F8 | 48 | 62 | M | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| G1 | 49 | 58 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| G2 | 50 | 58 | F | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant | N |
| G3 | 51 | 32 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| G4 | 52 | 50 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| G5 | 53 | 65 | M | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant | N |
| G6 | 54 | 39 | - | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| G7 | 55 | 73 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIA | Malignant | N |
| G8 | 56 | 48 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| H1 | 57 | 64 | F | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | N |
| H2 | 58 | 64 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| H3 | 59 | 61 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| H4 | 60 | 53 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIA | Malignant | N |
| H5 | 61 | 67 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| H6 | 62 | 30 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | N |
| H7 | 63 | 65 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | N |
| H8 | 64 | 59 | F | Lung | Adenocarcinoma | 3 | T2N1M1 | IIA | Malignant | N |
| I1 | 65 | 58 | F | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | N |
| I2 | 66 | 51 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| I3 | 67 | 69 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | N |
| I4 | 68 | 60 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| I5 | 69 | 61 | F | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | N |
| I6 | 70 | 49 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| I7 | 71 | 72 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | N |
| I8 | 72 | 36 | F | Lung | Adenocarcinoma | 3 | T2N2M0 | IIIA | Malignant | N |
| J1 | 73 | 56 | F | Lung | Adenocarcinoma | 3 | T2AN1M0 | IIA | Malignant | N |
| J2 | 74 | 75 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | N |
| J3 | 75 | 74 | M | Lung | Adenocarcinoma (sparse) | * | T2N0M0 | IB | Malignant | N |
|
